This study aims to investigate whether 11 candidate single nucleotide polymorphisms (SNPs) in vitamin D and calcium pathway genes (CYP2R1, CYP24A1, and CYP27B1) are associated with the risk of NAFLD. The gene discussed is CYP2R1; the disease is metabolic dysfunction-associated steatotic liver disease.